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Abstract 26 
Background & Aims: Therapeutic foods (RUTF) are used to treat severe acute malnutrition 27 
in children 5 years and under in low and middle income countries (LMI), while liquid 28 
nutritional supplements (ONS) are used in affluent societies. With globalisation and 29 
economic growth in LMI, there will be an inclination to move towards practices applied in 30 
affluent countries. This study compared the effect of supplementation with a RUTF and an 31 
ONS, on nutritional outcomes in mildly underweight children. 32 
 33 
Methods: 68 Pakistani (5 to 10 y), mildly underweight (weight Z-score: -2 to -1) children 34 
randomly received either RUTF or ONS (500 kcal/day), in addition to their habitual diet for 35 
four weeks. Weight, height, skinfolds and their changes during intervention, were compared 36 
between the two groups and at follow up, post-supplementation. 37 
 38 
Results: All nutritional outcomes and height improved with both supplements, but net weight 39 
gain (kg) and changes from baseline for weight, height, triceps and sub-scapular thickness Z-40 
scores did not differ between the two supplements [mean (SD), RUTF vs ONS; weight gain 41 
(kg), 0.59 (0.30) vs 0.65 (0.42), p=0.483; weight Z-score, 0.12 (0.09) vs 0.15 (0.13), p=0.347; 42 
height Z-score, 0.04 (0.08) vs 0.04 (0.08), p=0.908; triceps Z-score, 0.29 (0.24) vs 0.31 43 
(0.23), p=0.796; subscapular Z-score, 0.37 (0.29) vs 0.31 (0.25), p=0.385]. Weight gain (0.6 44 
kg) for both groups was lower than anticipated (2 kg). Post-supplementation, there was a 45 
tendency for weight and height Z-score to return to baseline. 46 
Conclusions: RUTF and ONS are equivalently effective in improving nutritional outcomes 47 
in children 5 to 10 y at risk of malnutrition but the observed benefit is less than expected and 48 
not sustainable. 49 
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Trial registration: This trial was registered at www.controlled-trials.com reference: 50 
ISRCTN51555749 51 
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Introduction 54 
Malnutrition, while being a preventable condition, remains a major cause of child mortality 55 
and global disease burden. Nutritional stunting, severe wasting, and intrauterine growth 56 
restriction together account for over 2 million deaths for children younger than 5 years [1]. 57 
The large majority of malnourished children live in the Asian continent and particularly in the 58 
low and middle income (LMI) countries such as in Pakistan, India and Bangladesh [1]. In 59 
these countries, childhood malnutrition is associated with various social, economic, and 60 
political factors such as poverty, household food insecurity, and lack of health services [1]. 61 
The main focus of the management of malnutrition in these countries remains the treatment 62 
of severe acute malnutrition, using ready-to-use therapeutic food (RUTF) [2], an energy 63 
dense paste which  can be stored at room temperature for several months [3, 4], and can be 64 
eaten without the addition of water or milk, thus reducing the risk of contamination [2]. 65 
RUTF is very effective and safe in the treatment of severe acute malnutrition in pre-school 66 
children (<5 y) in LMI countries [4-6] but there is no evidence of efficacy in older children 67 
and only short-term evidence of efficacy in treatment of moderate malnutrition [7]. 68 
 Instead of this, in more affluent countries, liquid, oral nutritional supplements (ONS) 69 
are widely used for treatment of disease-associated malnutrition and poor appetite. Most of 70 
the evidence on their effectiveness comes from studies in elderly patients [8] but in children 71 
research is scarce. In children with cystic fibrosis, a non-significant effect was observed after 72 
12 month of ONS supplementation [9], while in children with fussy eating behaviour and 73 
food avoidance, a multimodal intervention with dietary counselling and ONS was more 74 
effective than dietary counselling alone [10]. 75 
As many LMI countries are now entering economic transition, the focus is being 76 
directed more to children who suffer from moderate malnutrition. It is generally suggested 77 
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that prevention programmes, in children at nutrition risk, will be more effective than 78 
treatment of existing malnutrition [11, 12]. However, RUTF is increasingly used in some 79 
countries for treatment of moderate malnutrition  and with  globalisation and industry vested 80 
interests, there will be an inclination for LMI countries to move towards healthcare therapies 81 
and technologies used in more affluent societies. 82 
The primary aim of this study is to compare the impact of RUTF and ONS on weight 83 
change, growth and other nutritional parameters in free-living, mildly underweight primary 84 
school children in a LMI country. Our two a priori hypotheses were that: a) mildly 85 
underweight children, will gain weight faster while taking supplements and b) that RUTF and 86 
ONS will be equally effective.  87 
  88 
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Subjects and Methods 89 
Participants and screening visit 90 
The study was conducted in a primary school in of Abbottabad district, Khyber 91 
Pakhtunkhwa, Pakistan, May to November 2013. Participants were primary school children 92 
aged 5 to 10 years at risk of malnutrition, as it was not thought ethical to offer temporary 93 
treatment to children with established undernutrition. For the purposes of this study, risk of 94 
malnutrition was defined as weight Z-score between -2 and -1 SD, based on previous 95 
research suggesting that mildly underweight children have double the risk of all-cause 96 
mortality compared to normal weight peers [13]. 97 
 Following explanation of the study and permission from the school, the caregivers 98 
and children were introduced to the researcher, who explained the purpose of the study and 99 
screened those interested in participating. Anthropometry was carried out according to the 100 
WHO standard operating procedures and was used to calculate Z-scores using the WHO 101 
standards http://www.who.int/childgrowth/en/. A health screening questionnaire was 102 
administered by a qualified physician and children with acute or chronic conditions likely to 103 
affect nutritional status and growth were excluded. Healthy children with weight Z-score 104 
between -2 to -1 SD were offered to participate in the intervention trial and children with a 105 
weight Z-score <-2 were advised to see their health professional for further review. The 106 
screened children who had a weight Z-score > -1 SD did not undergo any intervention, but 107 
had their anthropometry measurements repeated after four weeks. 108 
 109 
 110 
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Study design 111 
Eligible participants were randomly allocated by computerized randomization (Research 112 
Randomiser, version 3.0) [14] to receive either a RUTF, endorsed by WHO for management 113 
of severe acute malnutrition in children who are under 5 years  in LMI, or a medicinal, liquid 114 
ONS commonly used in affluent countries for treatment of disease associated malnutrition. 115 
The RUTF used (Plumpy’Nut; Nutriset, Malaunay, France) is a ready-made mixture of 116 
peanut, sugar, milk powder, minerals, vitamins and vegetable oil which is microbiologically 117 
safe [11, 15]. RUTF is individually packaged in airtight aluminium foil sachet, is a thick 118 
paste and tastes like peanut butter. The ONS (Fortini, Strawberry, Nutricia) was a proprietary, 119 
strawberry flavoured ready to drink sip feed available in 200 ml bottles. RUTF and ONS look 120 
different; therefore, it was impossible to blind participants to treatment allocation. For four 121 
weeks  the children in the RUTF group were provided with one sachet of RUTF daily (92 g, 122 
500 kcal/d), and the children in the ONS group were provided with nearly two bottles of 123 
ONS; 60ml of ONS was removed from one of the two bottles in order to provide 500 kcal/ 124 
day). The composition of RUTF and ONS is given in Table 1. 125 
 For those who participated in the RCT, height, weight, subscapular and triceps 126 
skinfold thickness, were measured before (baseline) and at the end of the supplementation, at 127 
four weeks then, within 15 months post supplementation. The supplements were delivered to 128 
the children by the researcher at school daily, in the morning and were asked to consume the 129 
supplements in addition to their regular diet.  Although, the students were not observed while 130 
taking the supplements, the empty bottles/sachet of the supplements were collected by the 131 
main researcher later the same day in order to check intervention compliance.  132 
 133 
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Caregiver opinions 134 
In depth structured group discussions were conducted with the caregivers of the RCT 135 
participants, once before the start of the study and again at the end of supplementation [16, 136 
17]. The researcher led the group discussions using predefined questions and each discussion 137 
lasted for approximately 30 minutes. Caregivers were asked questions regarding the appetite 138 
of their children before the start of supplements and after supplementation, acceptability of 139 
supplements, taste of supplement, side effects and any changes observed by them in their 140 
children after 4 weeks of supplementation.  141 
Statistical analysis  142 
The primary outcome was difference in weight Z-score change between the two groups after 143 
four weeks of supplementation. Secondary outcomes were differences between the two 144 
groups in changes of height, BMI and skinfold Z-scores. Changes within and between groups 145 
were assessed using paired and unpaired t-tests. The chi-squared test was used for differences 146 
in categorical variables between groups. Spearman rank correlation was used to explore the 147 
relationship between continuous variables. A General Linear Model was applied to associate 148 
changes in nutritional outcomes (weight and height Z-scores) with the duration of follow up, 149 
post-supplementation. Power calculation was based on data available from a previous study 150 
[2]. Thirty two subjects were required in each group to detect a mean difference of 0.5 kg 151 
weight gain between the two intervention groups, considering a pooled SD of 0.7 and a 152 
power of 80%.  153 
 154 
Ethics 155 
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The study was approved by the Research Ethics Committee of the College of Medical 156 
Veterinary and Life Sciences, University of Glasgow and of Ayub Medical College 157 
Abbottabad. Approval from the principals of the school was received prior to the start of the 158 
study. Explanations to the principals and caregivers were given in local language. The 159 
caregivers of all the participants gave written informed consent. This trial was registered at 160 
www.controlled-trials.com (reference: ISRCTN51555749).  161 
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Results 162 
Of 239 children screened, 74 (31%) children were eligible for the intervention study and 19 163 
(8%) had weight Z-score < -2 SD and were referred to their health professionals. A total of 68 164 
children (93% girls) were randomly enrolled in the study; 34 received RUTF and 34 received 165 
ONS (Figure 1); 128 of the 146 children (97% girls) with a weight Z-score > -1 SD agreed to 166 
have their measurements repeated after four weeks. Two children who admitted sharing their 167 
supplements with others were excluded from analysis. The majority of all students in the 168 
school considered for this study were girls, as the boys were enrolled in nearby private and 169 
government schools for cultural reasons.  170 
Compared with national demographic data, caregivers of the intervention groups were 171 
from low socioeconomic status, were uneducated, spent one third of their earning on food 172 
items, and had more people and siblings living in the same small house [18] (Supplementary 173 
Table 1).   174 
 175 
Nutritional outcomes 176 
At study enrolment there was no significant differences between the two groups (Table 2). 177 
Compared with baseline values, there was a significant increase in weight [mean, (SD)] in 178 
RUTF [0.59 (0.30) kg] and ONS group [0.65 (0.42) kg], after 28 days of supplementation 179 
(both p-values<0.0001 Table 2) but there was no significant difference in the extent of weight 180 
gain (i.e. change from baseline) between the two treatments (Figure 2). Similarly, the Z-181 
scores for BMI, height and skinfolds significantly increased following four weeks of 182 
supplementation in both the RUTF and ONS groups (Table 2) but were not different between 183 
the two interventions (Figure 2). The extent of change in weight Z-score during 184 
supplementation did not correlate with baseline weight Z-score for either groups (Spearman 185 
rho, p-value: RUTF: r=-0.013, p=0.945 and ONS: r=-0.049, p=0.787). Similarly, net weight 186 
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gain (kg) was independent of BMI Z-score at baseline (Spearman rho, p-value: RUTF: 187 
r=0.162, p=0.368 and ONS: r=-0.013, p=0.943). 188 
 In the group of children who did not qualify for the study (i.e. weight Z-score>-1 189 
SD), no significant changes were observed in weight (kg), or weight, height and BMI Z-190 
scores after 4 weeks (Table 2). Changes in all nutritional outcomes were significantly higher 191 
in the intervention groups compared with the control group (Figure 2). 192 
 193 
Changes at follow up 194 
Thirty two children in the RUTF and 29 in the ONS group were followed for a mean (SD) 195 
period of 5.9 (3.2) and 7.4 (2.3) months respectively after the end of supplementation. For 196 
both of the intervention groups, the duration of follow up post-supplementation was inversely 197 
correlated with the change in weight (Spearman rho, p-value: RUTF: r=-0.78, p<0.0001; 198 
ONS: r=-0.48, p=0.009) and height Z-scores (Spearman rho, p-value: RUTF: r=-0.87, 199 
p<0.0001; ONS: r=-0.76, p<0.0001) within the same period. The extent of this effect was 200 
independent of the type of supplement and its interaction with the duration of follow up, after 201 
we accounted for these factors using a General Linear Model.  202 
 203 
Caregivers’ opinions 204 
Most caregivers from RUTF (76%) and ONS (70%) group, (p=0.580) were pleased with the 205 
supplements and wanted to use them again provided that they were inexpensive or supplied 206 
free of cost. Ten (29%) children from the RUTF and 13 (39%) children from ONS group, 207 
(p=0.438) did not like the taste, 19 (56%) and 14 (41%) of the caregivers observed 208 
height/weight gain after four week supplementation with ONS and RUTF respectively, 209 
p=0.218.  In both groups, 6 (18%) caregivers observed loss of appetite for short duration, 210 
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while two (6%) caregivers in the RUTF group and five (15%) in the ONS group, (p=0.230) 211 
attributed side effects including nausea, abdominal pain and diarrhoea.  212 
 213 
 214 
  215 
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Discussion  216 
This community based RCT compared the equivalence of RUTF and ONS supplements in 217 
mildly underweight children between 5 to 10 years at risk of malnutrition, in a LMI country. 218 
We have shown that both supplements temporarily improved the nutritional status of the 219 
participants, with no difference between the interventions in all primary and secondary 220 
outcomes assessed. Although the children did show an average weight increase of 0.6 kg in 221 
the current study, this was much lower than the anticipated theoretical gain. The total extra 222 
energy supplied (500 kcal/day) for four weeks would have been expected to lead to an excess 223 
gain of approximately two kilograms. This suggests that at least 2/3 of the energy ingested 224 
may have been compensated, by eating less at other times. We have previously shown in a 225 
well-controlled, mechanistic, energy balance study that almost half of the energy provided by 226 
ONS was compensated for by eating less during a consecutive meal [19]. Energy 227 
compensation may explain to some extent, why supplementation trials in under- or 228 
malnourished children have found that observed weight gain rate was substantially less than 229 
predicted [20-22]. It two studies by the same group,  a mean weight gain of 0.7 to 0.89 kg  230 
was observed  after 12 weeks of  supplementation with either corn-soya flour or lipid based  231 
fortified spread in very young, undernourished infants in Malawi [21, 22]. 232 
It is often suggested that treatment effects are reduced because the supplements are 233 
not consumed, but in the current study we can be relatively assured that compliance was 234 
good. All the supplements were provided by the main researcher, the empty sachet and 235 
bottles were collected on the same day and no cooking was required, which may otherwise 236 
have adversely affected compliance [23]. This is also evident from the very small inter-237 
individual variation in weight gain following both nutritional interventions. It was also 238 
expected that more weight gain would be seen in those who are most undernourished and less 239 
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as children reach a normal weight for their age [4]. However, this was not evident in the 240 
current study, as no association was found between the participants’ nutritional status at 241 
baseline and the extent of weight gain at follow up. 242 
 Some children in both groups were dissatisfied with the consistency and the taste of 243 
the supplements which agrees with the results of previous research [15]. Similarly, 30% of 244 
the caregivers from the RUTF and ONS group perceived these supplements not to be 245 
beneficial for their children which is lower than another study in which 91% of the caregivers 246 
perceived RUTF to be of a therapeutic benefit to their severely malnourished children [15]. 247 
This may be due to the fact that our population was not severely malnourished, cultural 248 
factors and their effect on acceptability of the ready to use supplements, or due to the side 249 
effects some children experienced, particularly with the use of the ONS. Other studies have 250 
also demonstrated these side effects by the use of RUTF and therapeutic milk F-100 [15, 24, 251 
25]. 252 
 The main strengths of this study are the high compliance and the low number of drop 253 
outs, which might be explained by the fact that the study was scheduled between May to 254 
December, when movement of the children into other schools is not common [20]. The major 255 
limitation is the absence of a comparable untreated group, making it impossible to tell 256 
whether the gain in weight was truly a treatment effect as opposed, for example, to seasonal 257 
variation. However the gradual loss of weight following supplementation cessation and the 258 
absence of changes in the group which did not meet the study inclusion criteria, suggest that 259 
this is most likely to be a net effect of the intervention. Another limitation is that these 260 
children, albeit at risk of malnutrition, all had a weight Z-score within the -2 to -1 SDS (e.g. 261 
2nd to 15th centiles), making it likely that some may be naturally short or naturally slim rather 262 
than malnourished. However, these children did on average show weight gain, and more 263 
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importantly height increased during the supplementation period, with both of these declining 264 
at follow up. This suggests that many were at least relatively malnourished and on average 265 
our definition of malnutrition risk was valid and appropriate to use. Also, the poor socio-266 
economic characteristics of our intervention group mirror those seen in families of children at 267 
risk of malnutrition. Detailed body composition might have been more informative than 268 
skinfold measurement in this study, but variation in weight over a short period of intervention 269 
is most likely to be attributed to changes in fat rather than muscle stores. Assessment of 270 
habitual dietary intake during the intervention period would have also allowed us to estimate 271 
the extent of energy compensation from the use of the supplements despite limitations 272 
associated with dietary assessment methods [26]. Other limitations include the modest 273 
number of participants and the narrow age range of the participants which does not allow 274 
extrapolation of the findings of the current study to other age groups. The duration of the 275 
intervention had to be restricted due to various logistic reasons and in order to avoid the 276 
effect that school leave, and other festive periods (e.g. Ramadan) might have had in the 277 
routine dietary habits and lifestyle of the participants and their families. Also, while RUTF 278 
and ONS supplements were iso-caloric they differed in carbohydrate and fat composition and 279 
fluidity which are known to influence energy balance independently of calorific load [27, 28].  280 
 281 
Conclusion 282 
In conclusion, we have shown that use of ONS offer no additional benefit in improving 283 
nutritional parameters in free-living children 5 to 10 y at risk of malnutrition, compared with 284 
the use of RUTF, in LMI countries. Both nutritional supplements produced similar 285 
accelerated weight gain, but this was lower than expected and tended not to persist after 286 
supplementation stopped.   287 
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Figure Legends 388 
Figure 1: Flow chart of participant screening, recruitment and treatment allocation and 389 
follow up 390 
 391 
Figure 2: Change in nutritional outcomes in the intervention groups and those children who 392 
were screened but did not meet the inclusion criteria 393 
RUTF, ready to use therapeutic food; ONS, oral nutritional supplement; NO-INTERV: 394 
children who did not meet the study inclusion criteria; * indicates p<0.05 with other groups 395 
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Table 1: Nutritional composition of RUTF and ONS 
 
 Per 100 g  Delivered per day 
 RUTF ONS  RUTF  
(92 g) 
ONS 
(340ml)  
 
Energy (kcal) 
 
545 
 
150 
 
500          
 
510 
             ( kJ) 2281 630 2093 2142 
Macronutrients     
     Protein, g 13.6 3.4 12.5 11.56 
     Carbohydrates, g 35.0 18.8 32.2 63.92 
     Fat, g 35.7 6.8 32.9 23.12 
Minerals     
    Sodium, mg 189 67                           <189 227.8 
    Potassium, mg 1111 140 1051 476 
    Calcium, mg 320 84 276 285.6 
    Phosphorus, mg 394 75 276 255 
    Magnesium, mg 92 17          84.6 57.8 
    Zinc, mg 14 1.5 12.9 5.1 
    Iron, mg 11.5 1.5 10.6 5.1 
RUTF, ready to use therapeutic food; ONS, oral nutritional supplement 
 
Table 2: Nutritional outcomes by group during the course of the study 
 
 Intervention Before 
supplementation 
After 
supplementation 
Follow up 
post-supplementation 
Change  
during supplementation 
Weight, kg RUTF 21.8 (2.6) 22.4 (2.7) 23.3 (2.7) 0.59 (0.30); p<0.0001 
 ONS 21.0 (1.8) 21.6 (1.9) 22.9 (1.9) 0.65 (0.42); p<0.0001 
 NO-INTERV 28.7 (5.2) 28.9 (5.5) - 0.26 (1.54); p=0.061 
Height, cm RUTF 126.3 (7.2) 127.0 (7.3) 129.4 (6.9) 0.69 (0.49); p<0.0001 
 ONS 124.5 (4.3) 125.2 (4.4) 128.2 (4.8) 0.68 (0.44); p<0.0001 
 NO-INTERV 136.2 (8.7) 136.6 (8.6) - 0.44 (0.86); p<0.0001 
BMI, kg/m2 RUTF 13.6 (0.9) 13.8 (1.0) 13.8 (0.9) 0.21 (0.24); p<0.0001 
 ONS 13.5 (0.8) 13.8 (0.8) 13.9 (1.1) 0.27 (0.25); p<0.0001 
 NO-INTERV 15.4 (1.7) 15.4 (1.7) - 0.01 (0.68); p=0.786 
Weight Z-score  RUTF -1.33 (0.28) -1.21 (0.29) -1.27 (0.3) 0.12 (0.09); p<0.0001 
 ONS -1.34 (0.29) -1.2 (0.3) -1.24 (0.4) 0.15 (0.13); p<0.0001 
 NO-INTERV 0.16 (0.7) 0.15 (0.8) - -0.01 (0.20); p=0.484 
Height Z-score RUTF -0.51 (0.7) -0.47 (0.65) -0.54 (0.6) 0.04 (0.08); p=0.005 
 ONS -0.54 (0.6) -0.50 (0.6) -0.55 (0.6) 0.04 (0.07); p=0.005 
 NO-INTERV 0.87 (1.0) 0.86 (1.0) - 0.01 (0.15); p=0.721 
BMI Z-score RUTF -1.59 (0.7) -1.45 (0.73) -1.61 (0.7) 0.15 (0.18); p<0.0001 
 ONS -1.58 (0.6) -1.39 (0.60) -1.42 (0.7) 0.19 (0.19); p<0.0001 
 NO-INTERV -0.48 (0.9) -0.49 (0.86) - -0.01 (0.34); p=0.770 
Triceps, mm RUTF 7.6 (1.3) 7.9 (1.3) 7.7 (1.3) 0.29 (0.24); p<0.0001 
 ONS 7.5 (1.5) 7.8 (1.4) 7.7 (1.3) 0.31 (0.23); p<0.0001 
Subscapular, mm RUTF 5.4 (0.8) 5.7 (0.8) 5.4 (1.0) 0.37 (0.29); p<0.0001 
 ONS 5.0 (0.9) 5.3 (0.9) 5.1 (0.8) 0.31 (0.25); p<0.0001 
Triceps Z-score RUTF -0.96 (0.6) -0.83 (0.6) -0.95 (0.6) 0.13 (0.13); p<0.0001 
 ONS -1.04 (0.71) -0.89 (0.65) -0.99 (0.6) 0.14 (0.12); p<0.0001 
Subscapular Z-score RUTF -0.61 (0.6) -0.39 (0.6) -0.65 (0.6) 0.21 (0.19); p<0.0001 
 ONS -0.85 (0.68) -0.64 (0.63) -0.84 (0.6) 0.21 (0.20); p<0.0001 
RUTF, ready to use therapeutic food; ONS, oral nutritional supplement; NO-INTERV: children who did not meet the study inclusion criteria 
 
